Replies to post #46780 on Biotech Values

[kaki72]

The interim analysis was an unscheduled event, so the question is why ? I agree with you, it is just for better future financing deals. The company needs to raise cash to keep going on the operations, by selling stock equities or partnership. If they wait for the 1st phaseIII to be fully completed it may be too late in terms of pps performance. So an interim analysis is appropriate and if positive it will give a boost to the pps and then the company can negotiate a good deal. By the way there was a huge volume yesterday, probably some huge buyers who believe it. jmo and glta